Harmonic Discovery uses a machine learning platform to facilitate drug discovery. The platform combines several aspects of traditional discovery, such as examining the atom and bond makeup of kinase drugs, according to a Sept. 8 Harmonic Discovery news release.
The funding round was led by Innovation Endeavors with participation from Fifty Years, Y Combinator, Boom Capital and Caffeinated Capital.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
